0001209191-20-052724.txt : 20201001 0001209191-20-052724.hdr.sgml : 20201001 20201001183822 ACCESSION NUMBER: 0001209191-20-052724 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201001 FILED AS OF DATE: 20201001 DATE AS OF CHANGE: 20201001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glickman Richard M CENTRAL INDEX KEY: 0001352637 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37410 FILM NUMBER: 201217475 MAIL ADDRESS: STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION STREET 2: 1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: V8Z7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ESSA Pharma Inc. CENTRAL INDEX KEY: 0001633932 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 BUSINESS PHONE: (778) 331-0962 MAIL ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-10-01 0 0001633932 ESSA Pharma Inc. EPIX 0001352637 Glickman Richard M C/O ESSA PHARMA INC. 999 WEST BROADWAY, SUITE 720 VANCOUVER A1 V5Z 1K5 BRITISH COLUMBIA, CANADA 1 0 0 0 Common Shares 38750 D Options 4.90 2022-03-21 2028-02-21 Common Shares 8250 D Options 4.90 2022-03-21 2024-05-21 Common Shares 3750 D Options 3.81 2023-03-08 2029-02-08 Common Shares 10000 D Options 3.23 2023-11-04 2029-10-04 Common Shares 30000 D Options 4.67 2022-11-30 2029-10-30 Common Shares 25000 D /s/ Richard Glickman 2020-10-01